{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:06:14Z","timestamp":1787727974236,"version":"build-2784847793"},"reference-count":48,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007543","name":"Grantov\u00e1 Agentura, Univerzita Karlova","doi-asserted-by":"publisher","award":["Progres Q40\/05"],"award-info":[{"award-number":["Progres Q40\/05"]}],"id":[{"id":"10.13039\/100007543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007543","name":"Grantov\u00e1 Agentura, Univerzita Karlova","doi-asserted-by":"publisher","award":["260543\/2020"],"award-info":[{"award-number":["260543\/2020"]}],"id":[{"id":"10.13039\/100007543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007543","name":"Grantov\u00e1 Agentura, Univerzita Karlova","doi-asserted-by":"publisher","award":["260 549"],"award-info":[{"award-number":["260 549"]}],"id":[{"id":"10.13039\/100007543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007543","name":"Grantov\u00e1 Agentura, Univerzita Karlova","doi-asserted-by":"publisher","award":["GAUK 3462\/18"],"award-info":[{"award-number":["GAUK 3462\/18"]}],"id":[{"id":"10.13039\/100007543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["GACR 19-14497S"],"award-info":[{"award-number":["GACR 19-14497S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["INOMED (CZ.02.1.01\/0.0\/0.0\/18_069\/0010046)"],"award-info":[{"award-number":["INOMED (CZ.02.1.01\/0.0\/0.0\/18_069\/0010046)"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Bile acids (BA) play a significant role in the pathophysiology of nonalcoholic steatohepatitis (NASH). The present study evaluates the modulation of bile acid metabolomics by atorvastatin, a cholesterol-lowering agent commonly used to treat cardiovascular complications accompanying NASH. NASH was induced in mice by 24 weeks of consuming a high\u2013saturated fat, high-fructose, and high-cholesterol diet (F), with atorvastatin administered orally (20 mg\/kg\/day) during the last three weeks. Biochemical and histological analyses confirmed the effectiveness of the F diet in inducing NASH. Untreated NASH animals had significantly reduced biliary secretion of BA and increased fecal excretion of BA via decreased apical sodium-dependent bile salt transporter (Asbt)-mediated reabsorption. Atorvastatin decreased liver steatosis and inflammation in NASH animals consistently with a reduction in crucial lipogenic enzyme stearoyl\u2013coenzyme A (CoA) desaturase-1 and nuclear factor kappa light chain enhancer of activated B-cell pro-inflammatory signaling, respectively. In this group, atorvastatin also uniformly enhanced plasma concentration, biliary secretion and fecal excretion of the secondary BA, deoxycholic acid (DCA). However, in the chow diet\u2013fed animals, atorvastatin decreased plasma concentrations of BA, and reduced BA biliary secretions. These changes stemmed primarily from the increased fecal excretion of BA resulting from the reduced Asbt-mediated BA reabsorption in the ileum and suppression of synthesis in the liver. In conclusion, our results reveal that atorvastatin significantly modulates BA metabolomics by altering their intestinal processing and liver synthesis in control and NASH mice.<\/jats:p>","DOI":"10.3390\/ijms22126468","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T21:58:32Z","timestamp":1623880712000},"page":"6468","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Atorvastatin Modulates Bile Acid Homeostasis in Mice with Diet-Induced Nonalcoholic Steatohepatitis"],"prefix":"10.3390","volume":"22","author":[{"given":"Hana","family":"Lastuvkova","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Charles University, Simkova 870, 500 03 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Alaei","family":"Faradonbeh","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Charles University, Simkova 870, 500 03 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolana","family":"Schreiberova","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Charles University, Simkova 870, 500 03 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milos","family":"Hroch","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Charles University, 500 03 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5769-9973","authenticated-orcid":false,"given":"Jaroslav","family":"Mokry","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Charles University, 500 03 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Faistova","sequence":"additional","affiliation":[{"name":"The Fingerland Department of Pathology, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, 500 03 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Nova","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Charles University, Simkova 870, 500 03 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radom\u00edr","family":"Hyspler","sequence":"additional","affiliation":[{"name":"Institute of Clinical Biochemistry and Diagnostics, University Hospital, Hradec Kralove, 500 03 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3907-2872","authenticated-orcid":false,"given":"Ivone Cristina","family":"Igreja Sa","sequence":"additional","affiliation":[{"name":"Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University, 500 03 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Nachtigal","sequence":"additional","affiliation":[{"name":"Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University, 500 03 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alzbeta","family":"Stefela","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, 500 03 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8769-4196","authenticated-orcid":false,"given":"Petr","family":"Pavek","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, 500 03 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Micuda","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Charles University, Simkova 870, 500 03 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ajg.2014.132","article-title":"Mortality from chronic liver diseases in diabetes","volume":"109","author":"Zoppini","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/hep.29359","article-title":"The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids","volume":"67","author":"Puri","year":"2018","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: A multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"101215","DOI":"10.1016\/j.diabet.2020.101215","article-title":"NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment","volume":"47","author":"Targher","year":"2020","journal-title":"Diabetes Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/2042018817741852","article-title":"Treating nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: A review of efficacy and safety","volume":"9","author":"Mills","year":"2018","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.2174\/1381612825666190117114305","article-title":"The Role of Statins in the Management of Nonalcoholic Fatty Liver Disease","volume":"24","author":"Doumas","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3201873","DOI":"10.1155\/2019\/3201873","article-title":"Simvastatin Reduces Hepatic Oxidative Stress and Endoplasmic Reticulum Stress in Nonalcoholic Steatohepatitis Experimental Model","volume":"2019","author":"Rodrigues","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1476-511X-10-23","article-title":"Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats","volume":"10","author":"Ji","year":"2011","journal-title":"Lipids Health Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/liv.12033","article-title":"Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats","volume":"33","author":"Okada","year":"2013","journal-title":"Liver. Int."},{"key":"ref_12","first-page":"275","article-title":"Effects of rosuvastatin and\/or beta-carotene on non-alcoholic fatty liver in rats","volume":"10","author":"Hammam","year":"2015","journal-title":"Res. Pharm. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plefa.2014.12.003","article-title":"Ameliorative potential of omega 3 fatty acids and HMG-CoA reductase inhibitors on experimentally-induced non-alcoholic steatohepatitis","volume":"96","author":"Kabel","year":"2015","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/dmrr.1157","article-title":"Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia","volume":"27","author":"Matafome","year":"2011","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.taap.2010.11.011","article-title":"Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment","volume":"251","author":"Vila","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1872-034X.2010.00769.x","article-title":"Pitavastatin inhibits hepatic steatosis and fibrosis in non-alcoholic steatohepatitis model rats","volume":"41","author":"Miyaki","year":"2011","journal-title":"Hepatol. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jhep.2013.02.024","article-title":"Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome","volume":"59","author":"Gan","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"G724","DOI":"10.1152\/ajpgi.00063.2016","article-title":"Statins improve NASH via inhibition of RhoA and Ras","volume":"311","author":"Schierwagen","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver. Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbalip.2017.12.002","article-title":"Activation of hepatic Nogo-B receptor expression-A new anti-liver steatosis mechanism of statins","volume":"1863","author":"Zhang","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1194\/jlr.M053124","article-title":"Atorvastatin induces bile acid-synthetic enzyme Cyp7a1 by suppressing FXR signaling in both liver and intestine in mice","volume":"55","author":"Fu","year":"2014","journal-title":"J. Lipid. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"G488","DOI":"10.1152\/ajpgi.00149.2016","article-title":"The influence of rosuvastatin on the gastrointestinal microbiota and host gene expression profiles","volume":"312","author":"Nolan","year":"2017","journal-title":"Am. J. Physiol. Gastrointest. Liver. Physiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s40168-017-0312-4","article-title":"Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism","volume":"5","author":"Lareu","year":"2017","journal-title":"Microbiome"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1194\/jlr.M067488","article-title":"Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice","volume":"57","author":"Schonewille","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1091\/mbc.e11-01-0047","article-title":"Prevention of estradiol 17beta-D-glucuronide-induced canalicular transporter internalization by hormonal modulation of cAMP in rat hepatocytes","volume":"22","author":"Zucchetti","year":"2011","journal-title":"Mol. Biol. Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1124\/dmd.116.071415","article-title":"Nonalcoholic Steatohepatitis Modulates Membrane Protein Retrieval and Insertion Processes","volume":"44","author":"Dzierlenga","year":"2016","journal-title":"Drug. Metab. Dispos."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e22035","DOI":"10.1002\/jbt.22035","article-title":"Misregulation of membrane trafficking processes in human nonalcoholic steatohepatitis","volume":"32","author":"Dzierlenga","year":"2018","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/hep.29025","article-title":"Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis","volume":"65","author":"McCommis","year":"2017","journal-title":"Hepatology"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Igreja S\u00e1, I.C., Tripska, K., Hroch, M., Hyspler, R., Ticha, A., Lastuvkova, H., Schreiberova, J., Dolezelova, E., Eissazadeh, S., and Vitverova, B. (2020). Soluble Endoglin as a Potential Biomarker of Nonalcoholic Steatohepatitis (NASH) Development, Participating in Aggravation of NASH-Related Changes in Mouse Liver. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21239021"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1021\/acs.jproteome.6b00984","article-title":"Gut Microbiota Modulation Attenuated the Hypolipidemic Effect of Simvastatin in High-Fat\/Cholesterol-Diet Fed Mice","volume":"16","author":"He","year":"2017","journal-title":"J. Proteome Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1007\/s10620-014-3028-3","article-title":"A possible role of chenodeoxycholic acid and glycine-conjugated bile acids in fibrotic steatohepatitis in a dietary rat model","volume":"59","author":"Jia","year":"2014","journal-title":"Dig. Dis. Sci."},{"key":"ref_32","first-page":"17","article-title":"The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis and related cardiovascular risk","volume":"71","author":"Athyros","year":"2017","journal-title":"Expert Panel Statement. Metab."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Sigler, M.A., Congdon, L., and Edwards, K.L. (2018). An Evidence-Based Review of Statin Use in Patients With Nonalcoholic Fatty Liver Disease. Clin. Med. Insights Gastroenterol., 11.","DOI":"10.1177\/1179552218787502"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4093\/dmj.2016.40.5.376","article-title":"Statins Increase Mitochondrial and Peroxisomal Fatty Acid Oxidation in the Liver and Prevent Non-Alcoholic Steatohepatitis in Mice","volume":"40","author":"Park","year":"2016","journal-title":"Diabetes Metab. J."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Chong, L.W., Hsu, Y.C., Lee, T.F., Lin, Y., Chiu, Y.T., Yang, K.C., Wu, J.C., and Huang, Y.T. (2015). Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells. BMC Gastroenterol., 15.","DOI":"10.1186\/s12876-015-0248-8"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"112784","DOI":"10.1016\/j.jep.2020.112784","article-title":"UPLC\/Q-TOF-MS\/MS-based metabolomics revealed the lipid-lowering effect of Ilicis Rotundae Cortex on high-fat diet induced hyperlipidemia rats","volume":"256","author":"Yang","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/omi.2017.0130","article-title":"Atorvastatin Treatment Modulates the Gut Microbiota of the Hypercholesterolemic Patients","volume":"22","author":"Khan","year":"2018","journal-title":"Omics"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bbrc.2014.11.054","article-title":"Metformin enhances the anti-adipogenic effects of atorvastatin via modulation of STAT3 and TGF-beta\/Smad3 signaling","volume":"456","author":"Kim","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41598-017-19013-2","article-title":"Effect of atorvastatin on the gut microbiota of high fat diet-induced hypercholesterolemic rats","volume":"8","author":"Khan","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","article-title":"Bile acids and the gut microbiome","volume":"30","author":"Ridlon","year":"2014","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejphar.2015.12.043","article-title":"Lipid-lowering agents inhibit hepatic steatosis in a non-alcoholic steatohepatitis-derived hepatocellular carcinoma mouse model","volume":"772","author":"Orime","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11745-003-1093-x","article-title":"Pitavastatin ameliorates severe hepatic steatosis in aromatase-deficient (Ar-\/-) mice","volume":"38","author":"Egawa","year":"2003","journal-title":"Lipids"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1194\/jlr.M038331","article-title":"Bile acid and sterol metabolism with combined HMG-CoA reductase and PCSK9 suppression","volume":"54","author":"Parker","year":"2013","journal-title":"J. Lipid. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.20784","article-title":"CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice","volume":"42","author":"Wagner","year":"2005","journal-title":"Hepatology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e3348","DOI":"10.7717\/peerj.3348","article-title":"Atorvastatin alters the expression of genes related to bile acid metabolism and circadian clock in livers of mice","volume":"5","author":"Li","year":"2017","journal-title":"PeerJ"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1194\/jlr.M053785","article-title":"Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH","volume":"56","author":"Ioannou","year":"2015","journal-title":"J. Lipid Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"116643","DOI":"10.1016\/j.lfs.2019.116643","article-title":"High soluble endoglin levels regulate cholesterol homeostasis and bile acids turnover in the liver of transgenic mice","volume":"232","author":"Dolezelova","year":"2019","journal-title":"Life Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/12\/6468\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:17:13Z","timestamp":1760163433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/12\/6468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,16]]},"references-count":48,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["ijms22126468"],"URL":"https:\/\/doi.org\/10.3390\/ijms22126468","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,16]]}}}